16:07 EST Viridian Therapeutics files to sell 15.02M shares of common stock for holders
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on VRDN:
- Viridian Therapeutics price target lowered to $29 from $46 at B. Riley
- Viridian Therapeutics price target lowered to $38 from $42 at JMP Securities
- Viridian Therapeutics reports Q3 EPS ($1.09), consensus ($1.24)
- VRDN Upcoming Earnings Report: What to Expect?
- Viridian Therapeutics price target lowered to $35 from $44 at RBC Capital